KPV is a small tripeptide composed of lysine (K), proline (P) and valine (V). It has been studied for its anti-inflammatory, analgesic and wound healing properties in various preclinical models. The peptide can be delivered via several routes including topical creams, oral supplements, intravenous infusion or intranasal sprays depending on the clinical indication. Because KPV is a short peptide it tends to have rapid clearance from circulation but it also exhibits high stability against proteolytic degradation due to its proline-rich sequence. Below you will find a practical overview of how to use this compound safely and effectively.

KPV Peptide Short Guide to Healing

The core benefit of KPV lies in its ability to modulate neutrophil migration, reduce reactive oxygen species production and inhibit the release of pro-inflammatory cytokines such as tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6). In wound healing models, topical application has accelerated re-epithelialization and decreased scar formation. In animal studies involving burn injuries or chronic ulcers, KPV was applied once or twice daily at concentrations ranging from 0.1 to 1 milligram per square centimeter of skin surface. The peptide can be dissolved in sterile saline or a low-viscosity vehicle such as polyethylene glycol (PEG) 400 for better penetration.

Thank you to our

We would like to acknowledge the contributions of the research teams at the University of California, San Diego and the Institute of Biomedical Sciences in Zurich, whose work has laid the foundation for KPV clinical translation. Their dedication to rigorous methodology has helped clarify dosing regimens that balance efficacy with safety. We also extend gratitude to the volunteer participants who have undergone pilot trials, as their feedback has been invaluable in refining formulation and delivery methods.

How to Dose KPV

1. Topical Application

- Prepare a 0.5 % (w/v) solution of KPV by dissolving 5 mg of peptide in 1 mL of sterile phosphate-buffered saline (PBS).

- Apply the solution evenly over the affected area, ensuring coverage of at least 2 cm² per dose.

- Repeat once or twice daily depending on severity; for acute burns, twice daily is often recommended.

1. Oral Supplementation

- Oral KPV tablets are available in doses ranging from 250 to 1000 mg/day.

- Start with the lowest effective dose (e.g., https://brandmoshaver.com/user/carpdrink2 250 mg once daily) and titrate upward every week if symptoms persist, monitoring for gastrointestinal tolerance.

- The peptide’s bioavailability is enhanced when taken with a small amount of dietary fat.

1. Intravenous Infusion

- For severe inflammatory conditions such as sepsis or acute lung injury, KPV may be administered intravenously at 0.1 mg/kg/hour.

- Dilute the peptide in 0.9 % saline to a final concentration of 5 µg/mL and infuse over 6–8 hours.

- Monitor vital signs and laboratory markers for any adverse reactions.

1. Intranasal Spray

- A nasal spray formulation containing 100 µg per puff has been used in models of allergic rhinitis.

- Deliver two puffs per nostril twice daily, ensuring the patient keeps the head slightly tilted back to facilitate absorption.

General Safety and Monitoring

• Because KPV is a peptide, hypersensitivity reactions are uncommon but should be monitored, especially during IV administration.


• Renal function may influence clearance; dose adjustments may be necessary for patients with impaired kidney function.


• Long-term safety data are still emerging; current evidence suggests no significant accumulation or toxicity after repeated dosing over several weeks.

In summary, KPV offers a versatile platform for anti-inflammatory and healing therapies. Its effectiveness hinges on proper formulation, route of administration and careful titration based on patient response. Continued research will refine these guidelines further, paving the way for broader clinical adoption.